The Treatment of Bipolar Disorder: Integrative Clinical Strategies and Future Directions

ISBN : 9780198801030

Andre F. Carvalho; Eduard Vieta
544 ページ
157 x 233 mm

Bipolar disorder is a chronic and debilitating mental illness affecting a significant proportion of the world's population. It is associated with significant impairments in health-related quality of life and psychosocial functioning, and has significant illness-related morbidity and heightened mortality rates due to medical comorbidities and suicide. The management of this disorder requires a complex combination of pharmacological and psychosocial interventions which can be challenging for clinicians. Written by world experts in the field of bipolar disorder, The Treatment of Bipolar Disorder: Integrative Clinical Strategies and Future Directions provides readers with a concise and comprehensive guide to the integrative management of bipolar disorder. This resource contains 31 chapters on the various management choices available, from both established and novel treatment areas, such as psychoeducation, psychotherapeutic interventions, neuromodulatory approaches and novel therapeutic targets. The complexity and diversity of the management choices available makes this a continually evolving field and necessitates forward thinking. By both discussing the current management of bipolar disorder, and the future developments available, this resource provides all clinicians working with patients with bipolar disorder an up-to-date and reflective guide to its management and what the future holds.


1: The current classification of bipolar disorders, Gin S. Malhi and Yulisha Byrow
2: Should the bipolar disorders be modelled dimensionally or categorically?, Gordon Parker and Amelia Paterson
3: The treatment of bipolar disorder on its early stages: challenges and developments., Michael Berk & Ajeet Singh - Singh AB, Eyre HA, Callaly E, Berk M
4: Evidence-based treatment of mania, Bernardo Ng and Mauricio Tohen
5: The treatment of bipolar mixed states, Sarah Kittel-Schneider
6: The treatment of rapid cycling bipolar disorder, Konstantinos N. Fountoulakis and Dimos Dimellis
7: Evidence-based treatment of bipolar depression, Mark A Frye, Paul E. Croarkin, Marin Veldic, Malik M Nassan, Katherine M Moore, Simon Kung, Susannah J. Tye, and William V. Bobo
8: Evidence-based maintenance treatment of bipolar disorder, Dina Popovic and Eduard Vieta
9: The treatment of type II bipolar disorder, Lakshmi N. Yatham and Muralidharan Kesavan
10: The treatment of Cyclothymia, Giulio Perugi, Giulia Vannucchi and Lorenzo Mazzarini
11: Psychological interventions for early stage Bipolar Disorder, Jan Scott
12: Psychotherapeutic interventions for bipolar disorder, María Reinares
13: The role of psychoeducation in the management of bipolar disorder, Francesc Colom
14: Functional remediation therapy for bipolar disorder, Carla Torrent, Caterina del Mar Bonnin and Anabel Martinez-Arán
15: Predominant polarity, polarity index and treatment selection in bipolar disorder, Sabrina C. da Costa, Joao L. de Quevedo, André F. Carvalho
16: The assessment and management of suicide risk in bipolar disorder, Zoltán Rihmer, Xénia Gonda, and Péter Döme
17: Treatment implications for bipolar disorder co-occurring with anxiety syndromes and substance-abuse, Gustavo H. Vázquez, Alberto Forte, Sebastián Camino, Leonardo Tondo,and Ross J. Baldessarini
18: The impact of psychiatric comorbidity in the treatment of bipolar disorder: focus on eating disorders and ADHD, Anna I. Guerdjikova, Paul E. Keck, Jr., and Susan L. McElroy
19: Bidirectional relationships between general medical conditions and bipolar disorder: treatment considerations, Nefize Yalin, Danilo Arnone and Allan Y. Young
20: The treatment of bipolar disorder in women, Danielle Balzafiore, Thalia Robakis, Sarah Borish, Vena Budhan, Natalie Rasgon
21: The treatment of bipolar disorder in children and adolescents, Phillip Hazell
22: The treatment of bipolar disorder in the eldery, Gilberto S. Alves, Felipe Kenji Sudo, and Johannes Pantel
23: The management of treatment-resistant bipolar disorder, Salih Selek, Ives C. Passos Jair C. Soares
24: Staging and neuroprogression in bipolar disorder: treatment implications, Flavio Kapczinski & Ives Cavalcante Passos
25: Pharmacotherapy of bipolar disorder: impact on neurocognition, Vicent Balanzá-Martínez, Sofia Brissos, Maria Lacruz, Rafael Tabarés-Seisdedos
26: Cognitive enhancement in bipolar disorder: current evidence and methodological considerations, Kamilla W. Miskowiak & Lars Vedel Kessing
27: The role of electroconvulsive therapy (ECT) in bipolar disorder treatment, Roumen Milev
28: Neuromodulatory approaches for bipolar disorder: current evidences and perspectives, Andre Russowsky Brunoni, Bernardo de Sampaio Pereira Júnior, Izio Klein
29: The role of complementary and alternative therapies for the management of bipolar disorder, Arun V. Ravindran and Tricia L. da Silva
30: Novel therapeutic targets for bipolar disorder, Ioline D Henter and Rodrigo Machado-Vieira
31: The treatment of bipolar disorder in the era of personalized medicine: myth or promise?, Chiara Fabbri and Alessandro Serretti


Andre F. Carvalho is Associate Professor of Psychiatry at the Federal University of Ceara, Brazil. He has published more than a hundred publications in leading scientific journals. In addition, he has been elected vice-chair of the section of Private Practice Psychiatry (World Psychiatric Association) and is a member of the board of councilors of the International Society of Bipolar Disorder (ISBD).; Eduard Vieta is Professor of Psychiatry at the University of Barcelona and Chair of the Department of Psychiatry and Psychology at the Hospital Clinic, where he also leads the Bipolar Disorders Program in Barcelona, Catalonia, Spain. His unit is one of the worldwide leaders in clinical care, teaching and research on bipolar disorder. He also leads the Bipolar Research Program at the Spanish Research Network on Mental Diseases (CIBERSAM) and is the most cited scientist worldwide in the field of bipolar disorder over the last 5 years and one of the world's most influential scientific minds, according to Thompson Reuters.